These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2820619)

  • 1. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.
    Riis BJ; Jensen J; Christiansen C
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):327-34. PubMed ID: 2820619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins.
    Jensen J; Riis BJ; Christiansen C
    Br J Obstet Gynaecol; 1987 Feb; 94(2):136-41. PubMed ID: 3030392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
    Johansen JS; Riis BJ; Delmas PD; Christiansen C
    Eur J Clin Invest; 1988 Apr; 18(2):191-5. PubMed ID: 2968266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.
    Thomsen K; Riis BJ; Johansen JS; Christiansen C; Rødbro P
    Gynecol Endocrinol; 1987 Jun; 1(2):169-75. PubMed ID: 2972170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause.
    Polatti F; Capuzzo E; Viazzo F; Colleoni R; Abbiati I; Nappi RE
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):49-53. PubMed ID: 9926892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Riis BJ; Christiansen C
    Eur J Clin Invest; 1991 Dec; 21(6):601-7. PubMed ID: 1838079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss.
    Riis BJ; Thomsen K; Strøm V; Christiansen C
    Am J Obstet Gynecol; 1987 Jan; 156(1):61-5. PubMed ID: 3541622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Vitale C; Fini M; Leonardo F; Rossini P; Cerquetani E; Onorati D; Rosano GM
    Maturitas; 2001 Dec; 40(3):239-45. PubMed ID: 11731185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P; Dauzat M; Abramovici Y; Deklunder G; Body G; Crepin G; Denis A; Favier M
    Gynecol Obstet Fertil; 2000; 28(7-8):509-17. PubMed ID: 10996962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
    Christiansen C; Christensen MS; Transbøl I
    Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of hormone replacement therapy with estradiol valerate and cyproterone acetate in perimenopausal women].
    Tinelli FG; Tinelli A; Sena T
    Minerva Ginecol; 2002 Feb; 54(1):67-73. PubMed ID: 11828273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
    Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
    Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.